Evaluation of PD-L1 Expression and Anti-<i>EGFR</i> Therapy in <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer.

Medicina (Kaunas) · 2025 · PMC12388373 · PMID 40870512

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

did not reach statistical significancep = 0.101not close (p > 0.1)

However, this difference did not reach statistical significance ( p = 0.101).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Evaluation of PD-L1 Expression and Anti-&lt;i&gt;EGFR&lt;/i&gt; Therapy in &lt;i&gt;EGFR&lt;/i&gt;-Mutant Non-Small-Cell Lung Cancer.

The sentences

Evaluation of PD-L1 Expression and Anti-<i>EGFR</i> Therapy in <i>EGFR</i>-Mutant Non-Small-Cell Lung Cancer.